• Users Online: 1243
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
Year : 2020  |  Volume : 25  |  Issue : 2  |  Page : 86-89

Prediction of lipohypertrophy in patients with diabetes mellitus

1 Department of Medicine, MAGJ Hospital, Ernakulum, Kerala, India
2 Department of Medicine, St. Johns Medical College, Bengaluru, Karnataka, India

Correspondence Address:
Dr. Jonita Evett Fernandes
B5, Apartment 207, L and T South City, Arekere Mico Layout, Bengaluru - 560 076, Karnataka
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/jmgims.jmgims_58_19

Rights and Permissions

Introduction: Lipohypertrophy (LH) may result in variable absorption of insulin and affect glycemic control. Objectives: This study aimed to study the risk factors and prevalence of lipohypertrophy in diabetic patients at a tertiary hospital in South India. Methodology: 206 patients with diabetes mellitus aged over 18 years of age, on insulin therapy for over two years, were included in this study conducted at St Johns Medical Hospital to explore the prevalence and risk factors for development of lipohypertrophy. Demographics, duration of diabetes and insulin therapy, type of needles used, times of reuse, injection technique was recorded. The injection sites were inspected meticulously for the presence of lipohypertrophy. Results: 66 patients (32%) were found to have LH of which 62 had Type 2 diabetes and 4 had Type 1 diabetes. The median duration of diabetes was 15 years (IQR 10-20) and was higher in the group with LH (P=0.000). The duration of insulin therapy was 10 years (IQR 5-10.5) and was significantly higher in the group with LH (P=0.000). The commonest site for insulin injection was the abdomen and it was associated with LH (P=0.000).Patients reusing the needles over 6 times and those who failed to rotate injection sites had the highest frequency of LH(P=0.000). Conclusions: Patients on long term insulin should be advised against the reuse of needles to save on cost of therapy in view of increased risk of LH and glycemic variability. Physicians must reinforce proper insulin injection technique periodically and document lipohypertrophy if present.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded144    
    Comments [Add]    

Recommend this journal